Following the completion of the investment, the company expects to export 74% of the plant’s output in 2012, as opposed to 60% this year.
“Following these investments, the GSK plant in Brasov now exports medicine to over 80 countries worldwide. By comparison, at the end of 2010, the plant exported to 50 countries,” the company said in a news release.
The plant’s main export markets are France and Italy, covering 24% of all exports. Other export destinations for Brasov medicine include Japan and Turkey.
The GSK plant in Brasov started export activity in 2008.
For this year, GSK output at Brasov is estimated to reach 46 million boxes per year, compared to 42.3 million in 2010.
GSK operations in Romania include medicine wholesale, retail and production.